Jason Campagna
Equibles does not estimate personal net worth.
Get an email with a short summary when Inventiva S.A. publishes a filing, an earnings call transcript or a press release.
Get IVA alertsAbout Jason Campagna
Q32 Bio Inc. reported in an 8-K filed June 25, 2025 that Jason Campagna resigned as Chief Medical Officer, effective July 9, 2025. Q32 Bio Inc. reported in an 8-K filed March 27, 2024 that Jason Campagna was appointed Chief Medical Officer, effective March 25, 2024. The proxy statement of Q32 Bio Inc. reports total compensation of $1,549,488 for Jason Campagna in fiscal 2024, including a base salary of $494,854. Disclosed compensation is on record for 2 fiscal years. Inventiva S.A. is classified in the Biotechnology industry within the Healthcare sector. Q32 Bio Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Q32 Bio Inc. includes Albert Seymour, Ph.D. (CEO and Board Member), Jodie Morrison (CEO and Board Member), Paul G. Alloway, Ph.D. (CEO and COO) and 7 others.
“On June 20, 2025, Jason Campagna, M.D., Ph.D. resigned from his role as Chief Medical Officer of Q32 Bio Inc. (the “Company”), effective as of July 9, 2025.”
“On March 25, 2024, the Board appointed Jodie Morrison as our Chief Executive Officer and principal executive officer, Lee Kalowski as our Chief Financial Officer and President and principal financial officer and principal accounting officer, Jason Campagna as our Chief Medical Officer, and Shelia Violette as our Chief Scientific Officer and President of Research.”
Affiliation history
-
Q32 Bio Inc. (QTTB)
SEC 8-K
Current2024-03-25–present
-
Inventiva S.A. (IVA)
Source not stated
Current -
Q32 Bio Inc. (QTTB)
SEC 8-K
2024-03-25–2025-07-09
Company network
Leadership on record at Q32 Bio Inc.
- Albert Seymour, Ph.D. CEO, Board Member
- Jodie Morrison CEO, Board Member
- Paul G. Alloway, Ph.D. CEO, COO
- Tim Kelly CEO, COO
- Arthur O. Tzianabos, Ph.D. Chairman
- Mark Iwicki Chairman
- Charles Michaud, Jr. CFO, Chief Accounting Officer
- Lee Kalowski CFO
- Arthur Tzianabos Board Member
- Bill Lundberg Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Q32 Bio Inc. (QTTB) | M.D., Ph.D. Chief Medical Officer | $494,854 | $1,549,488 |
| 2023 | Q32 Bio Inc. (QTTB) | M.D., Ph.D. Chief Medical Officer | $459,680 | $680,927 |